Key Message
Quantifying the duration of the preclinical detectable phase is important for the design and evaluation of cancer screening programs. Different types of mathematical estimation approaches lead to different estimates of the preclinical detectable phase duration. We advise researchers to use the method that matches the data available, and to use multiple methods for estimation when possible, since no method is perfect.
Citations
Citations to this article as recorded by
- Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors
Rikesh Bhatt, Ardo van den Hout, Antonis C. Antoniou, Mitul Shah, Lorenzo Ficorella, Emily Steggall, Douglas F. Easton, Paul D. P. Pharoah, Nora Pashayan
Cancer.2024;[Epub] CrossRef - Estimating the Length of the Preclinical Detectable Phase for Open-Angle Glaucoma
Johan Aspberg, Anders Heijl, Boel Bengtsson
JAMA Ophthalmology.2023; 141(1): 48. CrossRef